Which has the lower trailing P/E, BIO or DVA?

DVA has the lower trailing P/E: BIO trades at 44.15 and DVA at 15.58. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or DVA?

Over the past five years, DVA grew revenue faster — BIO at a 0.29% CAGR versus DVA at 3.91%.

Is BIO or DVA more profitable?

BIO runs the higher net margin — BIO at 8.59% versus DVA at 6.05%.

How have BIO and DVA total returns compared?

Over the past 10 years, BIO delivered 9.02% and DVA delivered 10.64% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs DaVita Inc. (DVA)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and DaVita Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$9.80B

$364.26HealthcareDelayed quote: Aug 19, 2026, 4:00 PM EDT

DVA

DaVita Inc.

$11.38B

$177.27HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — BIO vs DVA

growth of $100 · dividends reinvested · last 10y

BIO +140.8% (+9.2%/yr)DVA +178.4% (+10.8%/yr)DVA compounded faster over this window

BIO DVA

BIO vs DVA: by the numbers

•DVA is the larger company ($11.38B vs $9.80B market cap).
•DVA trades at the lower trailing earnings multiple (15.58 vs 44.15 P/E), one valuation lens rather than an overall verdict.
•BIO converts more revenue to profit (8.59% vs 6.05% net margin).
•DVA grew revenue faster over the past five years (3.91% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	DVA
P/E ratio	44.15	15.58
Forward P/E	37.78	11.98
P/S ratio	3.77	0.84
P/B ratio	1.36	N/A
EV / EBITDA	27.33	7.74
FCF yield	3.62%	13.74%

Profitability

Metric	BIO	DVA
Gross margin	51.90%	31.02%
Operating margin	9.08%	15.06%
Net margin	8.59%	6.05%
ROE	3.10%	-114.70%
ROIC	1.54%	11.18%

Growth (annualized)

Metric	BIO	DVA
Revenue CAGR (5Y)	0.29%	3.91%
EPS CAGR (5Y)	-26.27%	8.25%
FCF CAGR (5Y)	-9.65%	7.44%
Total return CAGR (5Y)	-14.04%	6.05%

Frequently asked

Which has the lower trailing P/E, BIO or DVA?: DVA has the lower trailing P/E: BIO trades at 44.15 and DVA at 15.58. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or DVA?: Over the past five years, DVA grew revenue faster — BIO at a 0.29% CAGR versus DVA at 3.91%.
Is BIO or DVA more profitable?: BIO runs the higher net margin — BIO at 8.59% versus DVA at 6.05%.
How have BIO and DVA total returns compared?: Over the past 10 years, BIO delivered 9.02% and DVA delivered 10.64% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full DVA analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio DaVita P/E ratio Bio-Rad Laboratories ROE DaVita ROE Bio-Rad Laboratories operating margin DaVita operating margin Bio-Rad Laboratories revenue growth DaVita revenue growth Bio-Rad Laboratories free cash flow DaVita free cash flow

Bio-Rad Laboratories & DaVita appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.